Astrazeneca COVID-19 vaccine effective against variants found in India - (U.S. News & World Report via NewsPoints Desk)

  • AstraZeneca, citing a study, said its COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, as reported by U.S. News & World Report.

  • The University of Oxford study investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralize the variants.

  • An analysis by Public Health England (PHE) last week showed that vaccines developed by Pfizer and AstraZeneca offer protection of more than 90% against hospitalization from the Delta variant.

  • AstraZeneca said the latest results are built on the recent analysis by PHE.

To read more NewsPoints articles, click here.

Reference Articles